Position history for UBS Group AG's holdings in AXSOME THERAPEUTICS INC.
Current Value
$92.5M
Current Shares
547,195
Total Value Change
+$89.3M
Total Shares Change
+507,491
Increased |
| 547,195 |
+54.0% |
| $92.5M |
| 0.0% |
| $164.05 |
42 |
| 2025-Q4 | Increased | 355,318 | +67.3% | $64.9M | 0.0% | $148.79 | 44 |
| 2025-Q3 | Decreased | 212,451 | -64.3% | $25.8M | 0.0% | $117.62 | 0 |
| 2025-Q2 | Increased | 595,455 | +106.3% | $62.2M | 0.0% | $103.36 | 48 |
| 2025-Q1 | Increased | 288,647 | +95.9% | $33.7M | 0.0% | $118.53 | 46 |
| 2024-Q4 | Increased | 147,347 | +208.5% | $12.5M | 0.0% | $84.78 | 45 |
| 2024-Q3 | Increased | 47,762 | +20.3% | $4.3M | 0.0% | $89.64 | 32 |
| 2024-Q2 | Decreased | 39,704 | -35.3% | $3.2M | 0.0% | $80.50 | 0 |